European Adrenal Insufficiency Registry (EU-AIR): a comparative observational study of glucocorticoid replacement therapy

BACKGROUND: Increased morbidity and mortality associated with conventional glucocorticoid replacement therapy for primary adrenal insufficiency (primary AI; estimated prevalence 93–140/million), secondary AI (estimated prevalence, 150–280/million, respectively) or congenital adrenal hyperplasia (est...

Descripción completa

Detalles Bibliográficos
Autores principales: Ekman, Bertil, Fitts, David, Marelli, Claudio, Murray, Robert D, Quinkler, Marcus, Zelissen, Pierre MJ
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4049497/
https://www.ncbi.nlm.nih.gov/pubmed/24884782
http://dx.doi.org/10.1186/1472-6823-14-40

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4049497/
https://www.ncbi.nlm.nih.gov/pubmed/24884782
http://dx.doi.org/10.1186/1472-6823-14-40

Ejemplares similares